← SynDRA
EFONIDIPINE
SynDRA canonical compound SYN0029806 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | CACNA1C | CACNA1F | CACNA1G |
|---|
| Mechanism of action | calcium channel blocker |
|---|
| Indication | hypertension |
|---|
| Disease area | cardiology |
|---|
All known targets
- CACNA1C
- CACNA1H
- CACNA1D
- CACNA1F
- CACNA1G
- Cacna1g
Mechanisms of action (all sources)
- CACNA1H PORE BLOCKER
- calcium channel blocker
- CACNA1D BLOCKER
- CACNA1C BLOCKER
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Antihypertensive Agents
- Calcium Channel Blockers
- Calcium-Regulating Hormones and Agents
- Cardiovascular Agents
- Diuretics
- Membrane Transport Modulators
- Natriuretic Agents
Cross-references
Synonyms
- efonidipine hydrochloride
- zeria
- efonidipine HCl
- Efonidipino
- DTXCID7023988
- efonidipinum
- RefChem:590611
- CHEBI:135859
- Landel
- Efonidipine [INN]
- Efonidipine (INN)
- NCGC00182046-01
- C34H38N3O7P
- UNII-40ZTP2T37Q
- EFONIDIPINE [MI]
- SCHEMBL49637
- (+/-)-EFONIDIPINE
- EFONIDIPINE [WHO-DD]
- NZ-105 (efonidipine HCl)
- orb1305693
- SCHEMBL29379054
- GTPL12565
- CHEBI:146221
- HMS3886A09
- HMS5084M05
- EX-A3998
- Tox21_113418
- AC-389
- MFCD00865899
- s4977
- AKOS015967143
- CCG-270291
- CS-3623
- NCGC00182046-04
- BE179489
- DA-63117
- HY-12502
- CAS-111011-63-3
Look up EFONIDIPINE in the interactive SynDRA portal →